- Home
- PEN vs CAI Comparison
PEN vs CAI Comparison
Compare PEN & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- CAI
- Stock Information
- Founded
- PEN 2004
- CAI 2008
- Country
- PEN United States
- CAI United States
- Employees
- PEN N/A
- CAI N/A
- Industry
- PEN Medical/Dental Instruments
- CAI Medical Specialities
- Sector
- PEN Health Care
- CAI Health Care
- Exchange
- PEN Nasdaq
- CAI Nasdaq
- Market Cap
- PEN 10.6B
- CAI 9.4B
- IPO Year
- PEN 2015
- CAI 2025
- Fundamental
- Price
- PEN $272.98
- CAI $34.06
- Analyst Decision
- PEN Strong Buy
- CAI Strong Buy
- Analyst Count
- PEN 16
- CAI 6
- Target Price
- PEN $302.93
- CAI $35.50
- AVG Volume (30 Days)
- PEN 457.5K
- CAI 564.6K
- Earning Date
- PEN 10-29-2025
- CAI 11-12-2025
- Dividend Yield
- PEN N/A
- CAI N/A
- EPS Growth
- PEN 916.05
- CAI N/A
- EPS
- PEN 3.74
- CAI N/A
- Revenue
- PEN $1,280,152,000.00
- CAI $533,847,000.00
- Revenue This Year
- PEN $15.52
- CAI $59.70
- Revenue Next Year
- PEN $14.20
- CAI $50.34
- P/E Ratio
- PEN $72.91
- CAI N/A
- Revenue Growth
- PEN 12.92
- CAI 106.53
- 52 Week Low
- PEN $184.80
- CAI $25.40
- 52 Week High
- PEN $310.00
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- PEN 56.68
- CAI N/A
- Support Level
- PEN $270.54
- CAI N/A
- Resistance Level
- PEN $288.91
- CAI N/A
- Average True Range (ATR)
- PEN 7.36
- CAI 0.00
- MACD
- PEN -0.15
- CAI 0.00
- Stochastic Oscillator
- PEN 41.57
- CAI 0.00
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.